FDG PET/CT demonstration of pancreatic metastasis from prostate cancer - Abstract

Department of Radiology, PET Imaging Science Center, Keck School of Medicine, University of Southern California, Los Angeles, CA.

Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA; and Division of Cancer Medicine, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.

 

 

We report the hybrid FDG PET/CT appearance of a biopsy-proven pancreatic metastasis from prostate cancer in a man with castrate-resistant metastatic disease. The common sites of metastases from prostate cancer are bone and locoregional lymph nodes. Pancreas is an atypical location of metastasis from prostate cancer. PET/CT in this case helped with the targeted pathologic confirmation to differentiate primary pancreatic tumor from an unusual metastasis from prostate cancer which in turn affected the clinical management.

Written by:
Desai B, Elatre W, Quinn DI, Jadvar H.   Are you the author?

Reference: Clin Nucl Med. 2011 Oct;36(10):961-2.
doi: 10.1097/RLU.0b013e3182291d1a

PubMed Abstract
PMID: 21892064

UroToday.com Prostate Cancer Section